Skip to main navigation Skip to search Skip to main content

Electrosprayed Folic Acid-Conjugated Ursolic Acid Nanoparticles for Tumor Therapy

  • The Catholic University of Korea

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

We describe a simple method for the fabrication of folic acid-conjugated ursolic acid (FA-UA) nanoparticles using electrospraying. The FA-UA nanoparticles had an average size of 90.6 nm and exhibited greater cellular uptake compared with pristine UA and electrosprayed UA nanoparticles. We also evaluated the cytotoxicity of pristine UA, electrosprayed UA nanoparticles, and FA-UA nanoparticles over time and under different UA concentrations. In vitro, the FA-UA nanoparticles showed significantly higher cytotoxicity in KB cells compared with pristine UA and electrosprayed UA nanoparticles. These results were corroborated by LIVE/DEAD staining and fluorescence imaging of cancer cells. Thus, FA-UA nanoparticles can potentially be used for targeting drugs in cancer therapies. [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)573-576
Number of pages4
JournalMacromolecular Research
Volume26
Issue number7
DOIs
StatePublished - 1 Jul 2018

Bibliographical note

Publisher Copyright:
© 2018, The Polymer Society of Korea and Springer Science+Business Media B.V., part of Springer Nature.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • electrospraying
  • folic acid
  • tumor therapy
  • ursolic acid

Fingerprint

Dive into the research topics of 'Electrosprayed Folic Acid-Conjugated Ursolic Acid Nanoparticles for Tumor Therapy'. Together they form a unique fingerprint.

Cite this